bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/127985

ConsensusDriver Improves Upon Individual Algorithms For Predicting Driver Alterations In Different Cancer Types And Individual Patients -- A Toolbox For Precision Oncology

Bertrand, D.·Drissler, S.·Chia, B.·Koh, J. Y.·Li, C.·Suphavilai, C.·Tan, I. B.·Nagarajan, N.
View original source ↗Export metadata ↓

Abstract

BackgroundIn recent years, several large-scale cancer genomics studies have helped generate detailed molecular profiling datasets for many cancer types and thousands of patients. These datasets provide a unique resource for studying cancer driver prediction methods and their utility for precision oncology, both to predict driver genetic alterations in patient subgroups (e.g. defined by histology or clinical phenotype) or even individual patients.\n\nMethodsWe performed the most comprehensive assessment to date of 18 driver gene prediction methods, on more than 3,400 tumour samples, from 15 cancer types, to determine their suitability in guiding precision medicine efforts. These methods have diverse approaches, which can be classified into five categories: functional impact on proteins in general (FI) or specific to cancer (FIC), cohort-based analysis for recurrent mutations (CBA), mutations with expression correlation (MEC) and methods that use gene interaction network-based analysis (INA).\n\nResultsThe performance of driver prediction methods varies considerably, with concordance with a gold-standard varying from 9% to 68%. FI methods show relatively poor performance (concordance <22%) while CBA methods provide conservative results, but require large sample sizes for high sensitivity. INA methods, through the integration of genomic and transcriptomic data, and FIC methods, by training cancer-specific models, provide the best trade-off between sensitivity and specificity. As the methods were found to predict different subsets of drivers, we propose a novel consensus-based approach, ConsensusDriver, which significantly improves the quality of predictions (20% increase in sensitivity). This tool can be applied to predict driver alterations in patient subgroups (e.g. defined by histology or clinical phenotype) or even individual patients.\n\nConclusionExisting cancer driver prediction methods are based on very different assumptions and each of them can only detect a particular subset of driver events. Consensus-based methods, like ConsensusDriver, are thus a promising approach to harness the strengths of different driver prediction paradigms.

Source connections

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bertrand, D., Drissler, S., Chia, B., Koh, J. Y., Li, C., Suphavilai, C., Tan, I. B., Nagarajan, N.. 2017-04-18. ConsensusDriver Improves Upon Individual Algorithms For Predicting Driver Alterations In Different Cancer Types And Individual Patients -- A Toolbox For Precision Oncology. https://doi.org/10.1101/127985

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Cross-modal transfer enables zero-shot prediction of drug responses across cell types

Genetic perturbation responses capture the functional consequences of gene-level interventions, providing functional information for drug-response prediction beyond baseline gene expression. Within the same cellular context, genetic and chemical perturbations engage shared regulatory networks, providing a biological basis for transferring response information between perturbation modalities. Here we introduce GRAFT, a framework that combines genetic-to-chemical transfer with cross-context prediction to infer drug-induced transcriptional responses without drug measurements in the target context. Across benchmarked LINCS and external contexts, GRAFT improved response correlation, directional agreement and magnitude reconstruction over competing methods, particularly for drugs with context-dependent responses. GRAFT-Adapt further refines predictions of unmeasured responses using a small number of drug measurements from the target context. GRAFT-Atlas spans 13 cellular contexts and 7,856 drug catalog entries, comprising 102,128 predictions for drug-context combinations. The atlas captured recognizable pharmacological neighborhoods, shared functional programs, context-dependent transcriptional changes and structural-functional associations supported by molecular docking. Across ten iPSC lines from distinct donors, GRAFT identified candidate inter-donor differences, with functional support for selected candidates from measured genetic perturbation responses. Together, GRAFT enables perturbation-informed prediction and comparison of drug responses across cellular contexts.

bioinformatics↗
bioRxiv2026

Interpreting graph neural networks reveals microbial association patterns in inflammatory bowel diseases

Traditional machine learning models trained on gut microbiome abundance profiles can distinguish individuals with inflammatory bowel disease (IBD) from non-IBD individuals. However, their interpretation typically considers taxa in isolation, making it difficult to understand how associations between taxa contribute to predictions. Here, we inferred individual-specific microbial association networks from longitudinal metagenomics data of 106 individuals in HMP2/iHMP and used them to train and interpret graph neural network (GNN) models, which we compared with abundance-based models such as Random Forest (RF). Although RF achieved higher predictive performance (AUPRC ~0.59 vs 0.446), interpreting the GNNs revealed that their predictions relied on a densely connected module of co-abundant Bacteroidales species. Unlike the taxa prioritized by RF, these species were not differentially abundant between conditions. In an independent cohort, this module carried most of the predictive signal, and removing its associations reduced performance to near chance. These results show that coordinated association structure, rather than abundance shifts alone, is a feature of the IBD gut microbiome, and that interpreting GNNs can uncover such patterns that complement abundance-based analyses.

bioinformatics↗
bioRxiv2026

FateDriver: Weakly supervised dual-view graph learning for transition-specific prioritization of candidate regulators in cellular reprogramming

Cellular reprogramming supports regenerative medicine, yet the endogenous regulators of a specified source-to-target transition remain incompletely defined. Existing computational methods rank candidate regulators from network topology, trajectory dynamics, or cell-state labels, leaving unused the factors experimentally delivered to induce the transition. We present FateDriver, a weakly supervised dual-view graph neural network that jointly represents cells and genes from single-cell transcriptomes, treats the delivered factors as sparse gene-level labels, and ranks the remaining genes for a specified transition under a positive--unlabeled formulation. Across two OSKM datasets and one GMT dataset, FateDriver ranked first or second among six methods in recovering externally curated reference genes, exceeded a supervision-matched non-graph model despite weaker co-expression with the delivered factors, and achieved the highest recovery of protein targets of pluripotency-inducing chemical cocktails in both OSKM datasets. Holding either the source or the endpoint fixed yielded distinct candidate programs, including a DDX58--interferon axis associated with cells lacking endogenous pluripotency markers. Applying the same framework to candidate source--target pairs prioritized distinct candidate origins for two in vivo partially reprogrammed intestinal populations. FateDriver converts sparse experimental knowledge into transition-specific hypotheses for regulator prioritization from single-cell trajectories.

bioinformatics↗